Delivery Order SPE2DB22D2211-SPE2DB25FSFPQ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Timolol 0.5% Gel-Solution 5ML, with a ceiling value of $3,427.07. This competitively awarded, non-set-aside contract is classified as a firm fixed price delivery order with an ultimate completion date of July 31, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,109.14 to AmerisourceBergen Drug Corp for the supply of Timolol 0.25% Gel-Solution 5ML, an ophthalmic medication used to treat glaucoma and ocular hypertension. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 13, 2025. The contract was fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a delivery order valued at $10,886.71 to AmerisourceBergen Drug Corp for Timolol 0.5% Gel-Solution 5ML on September 18, 2025, with an ultimate completion date of September 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Timolol is a beta-blocker medication commonly used to treat glaucoma and ocular...
- The Defense Logistics Agency awarded a delivery order valued at $1,633.77 to AmerisourceBergen Drug Corp for the supply of Timolol 0.25% Gel-Solution 5ML, an ophthalmic medication used to treat glaucoma and ocular hypertension. The contract, awarded on July 11, 2025, with an ultimate completion date of July 14, 2025, was competitively awarded without set-aside designation under firm fixed-price terms. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,818.40 to AmerisourceBergen Drug Corp for the supply of Timolol 0.5% Gel-Solution 5mL, a topical ophthalmic medication commonly used to treat glaucoma and ocular hypertension. This firm fixed-price delivery order, issued on August 8, 2025, was competitively awarded with no set-aside designation and carries an ultimate completion date of August 11, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $10,963.88 to AmerisourceBergen Drug Corp for Timolol 0.5% Gel-Solution 5ML, an ophthalmic medication commonly used to treat glaucoma and ocular hypertension. The contract, issued on June 2, 2025, with an ultimate completion date of June 3, 2025, utilizes firm fixed price pricing and carries no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,800.72 to AmerisourceBergen Drug Corp for Timolol 0.25% gel-solution in 5ml quantities. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by October 29, 2025, just one day after the award date of October 28, 2025. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for the supply of Timolol 0.5% gel-solution in 5ml units, with a ceiling value of $2,263.62 and a firm fixed price structure. This delivery order, which is not set-aside and represents a competitively awarded contract, will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of April 23, 2025. The contract is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Timolol 0.25% Gel-Solution in 5ml quantities, with a ceiling value of $5,125.67 and a firm fixed price structure. The contract represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of December 1, 2025. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,514.00 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Timolol 0.25% Gel-Solution 5ML. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 29, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply requirements. This...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSFPQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,202.08 to AmerisourceBergen Drug Corp for Timolol 0.25% gel-solution in 5ml quantities. This competitively awarded, non-set-aside contract was executed on September 22, 2025, with an ultimate completion date of September 23, 2025, and utilizes firm fixed price terms. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its comprehensive supply of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company's extensive portfolio of federal contracts demonstrates its capability to fulfill diverse medical supply requirements across multiple therapeutic domains in support of military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers. This particular delivery order for Timolol, an ophthalmic medication used in glaucoma treatment, reflects the company's ongoing role in supplying essential pharmaceutical products to support military and federal health programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/22/25 |